DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Non-small cell lung cancer	R-HSA-5619066	map05223	5666823	None	drug-path
Toll-like receptor signaling pathway	R-HSA-168898	map04620	5666823	None	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	5666823	None	drug-path
Olfactory transduction	R-HSA-9751605	map04740	pentamidine	3651377	drug-path
Bladder cancer	R-HSA-9700206	map05219	pentamidine	3651377	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	pentamidine	3651377	drug-path
Focal adhesion	R-HSA-354113	map04510	pentamidine	3651377	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	pentamidine	3651377	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	pentamidine	3651377	drug-path
Melanogenesis	R-HSA-5662702	map04916	4,5-dianilinophthalimide	1697	drug-path
Glioma	Q9NZM4	map05214	4,5-dianilinophthalimide	1697	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	4,5-dianilinophthalimide	1697	drug-path
Alzheimer's disease	R-HSA-1643685	0	benserazide	2327	drug-path
Huntington's disease	R-HSA-1643685	0	benserazide	2327	drug-path
Olfactory transduction	R-HSA-9751605	map04740	benserazide	2327	drug-path
Parkinson's disease	R-HSA-1643685	0	benserazide	2327	drug-path
Complement and coagulation cascades	R-HSA-114591	map04610	benserazide	2327	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	benserazide	2327	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	benserazide	2327	drug-path
Long-term potentiation	R-HSA-9620244	map04720	benserazide	2327	drug-path